Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats

Journal of Neurotrauma

Volumn 21, Issue 7, 2004, Pages 923-931

  Akiyama, Chihiro ^a   Yuguchi, Takamichi ^b   Nishio, Masami ^a   Tomishima, Takahiro ^a   Fujinaka, Toshiyuki ^a   Taniguchi, Masaaki ^a   Nakajima, Yoshikazu ^a   Kohmura, Eiji ^c   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b YUKIOKA HOSPITAL   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Edema; Macrophage infiltration; PP1; Secondary damage; Spinal cord injury; Src family kinase inhibitor

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; INTERLEUKIN 1BETA; MESSENGER RNA; NEW DRUG; PROTEIN TYROSINE KINASE INHIBITOR; PYRAZOLOPYRIMIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; CONTUSION; DRUG EFFECT; DRUG MECHANISM; DRY WEIGHT METHOD; EDEMA; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MACROPHAGE; MACROPHAGE INFILTRATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY SPINAL CORD LESION; SPINAL CORD COMPRESSION; SPINAL CORD LESION; TECHNIQUE; WATER CONTENT;

ANIMALS; CAPILLARY PERMEABILITY; EDEMA; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; MACROPHAGES; PYRAZOLES; PYRIMIDINES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD COMPRESSION; SRC-FAMILY KINASES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3242892545     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/0897715041526230     Document Type: Article

References (34)

1. BARTHOLDI, D., and SCHWAB, M.E. (1997). Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 9, 1422-1438.
2. BARTHOLDI, D., RUBIN, B.P., and SCHWAB, M.E. (1997). VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 9, 2549-2560.
3. COBBS, C.S., CHEN, J., GREENBERG, D.A., et al. (1998). Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. Neurosci. Lett. 249, 79-82.
4. DEPRE, C., SHIPLEY, G.L., CHEN, W., et al. (1998). Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat. Med. 4, 1269-1275.
5. DINKEL, K., MACPHERSON, A., and SAPOLSKY, R.M. (2003). Novel glucocorticoid effects on acute inflammation in the CNS. J. Neurochem. 84, 705-716.
6. EARNHARDT, J.N., STREIT, W.J., ANDERSON, D.K., et al. (2002). Induction of manganese superoxide dismutase in acute spinal cord injury. J. Neurotrauma 19, 1065-1079.
7. ELICEIRI, B.P., PAUL, R., SCHWARTZBERG, P.L., et al. (1999). Selective requirement of Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915-924.
8. FUJINAKA, T., KOHMURA, E., YUGUCHI, T., et al. (2003). The morphological and neurochemical effects of diffuse brain injury on rat central noradrenergic system. Neurol. Res. 25, 35-41.
9. FUJIO, Y., and WALSH, K. (1999). Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274, 16349-16354.
10. FULTON, D., GRATTON, J.-P., McCABE, T.J., et al. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
11. GHIRNIKAR, R.S., LEE, Y.L., and ENG, L.F. (2001). Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat. J. Neurosci. Res. 64, 582-589.
12. HANKE, J.H., GARDNER, J.P., DOW, R.L., et al. (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271, 695-701.
13. HE, H., HIROKAWA, Y., LEVITZKI, A., et al. (2000). An Anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies. Cancer J. 6, 243-248.
14. HUNTER, T. (1987). A tail of two src's: mutatis mutandis. Cell 49, 1-4.
15. KOVACS, Z., IKEZAKI, K., SAMOTO, K., et al. (1996). VEGF and flt expression time kinetics in rat brain infarct. Stroke 27, 1865-1873.
16. LENNMYR, F., ATA, K.A., FUNA, K., et al. (1998). Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J. Neuropathol. Exp. Neurol. 57, 874-882.
17. LIN, T., HIRJI, N., STENTON, G.R., et al. (2000). Activation of Macrophage CD8: pharmacological studies of TNF and IL-1β production. J. Immunol. 164, 1783-1792.
18. MEDHURST, A.D., HARRISON D.C., READ S.J., et al. (2000). The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissue and disease models. J. Neurosci. Met. 98, 9-20.
19. MENG, F., and LOWELL, C.A. (1997). Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185, 1661-1670.
20. NAG, S., TAKAHASHI, J.L., KILTY, D.W., et al. (1997). Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56, 912-921.
21. ORLICEK, S.L., HANKE, J.H., and ENGLISH, B.K. (1999). The Src family-selective tyrosine kinase inhibitor PP1 blocks LSP and IFN-gamma-mediated TNF and iNOS production in murine macrophages. Shock 12, 350-354.
22. PACZYNSKI, R.P., VENKATESAN, R., DIRINGER, M.N., et al. (2000). Effects of fluid management on edema volume and midline shift in a rat model of ischemic stroke. Stroke 31, 1702-1708.
23. PAPAVASSILIOU, E., GOGATE, N., PROESCHOLDT, M., et al. (1997). Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 49, 451-460.
24. PAUL, R., ZHANG, Z.G., ELICEIRI, B.P., et al. (2001). Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 7, 222-227.
25. PLATE, K.H., and RISAU, W. (1995). Angiogenesis in malignant gliomas. Glia 15, 339-347.
26. RADISAVLJEVIC, Z., AVRAHAM, H., and AVRAHAM, S. (2000). Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J. Biol. Chem. 275, 20770-20774.
27. SCHLESSINGER, J. (2000). New role for Src kinases in control of cell survival and angiogenesis. Cell 100, 293-296.
28. SENGER, D.R., GALLI, S.J., DVORAK, A.M., et al. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
29. SHAH, O.J., KIMBALL, S.R., and JEFFERSON, L.S. (2002). The Src-family tyrosine kinase inhibitor PP1 interferes with the activation of ribosomal protein S6 kinases. Biochem. J. 366, 57-62.
30. SIX, I., KUREISHI, Y., LUO, Z., et al. (2002). Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS. Lett. 532, 67-69.
31. SKÖLD, M., CULLHEIM, S., HAMMARBERG, H., et al. (2000). Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12, 3675-3686.
32. + exchanger inhibitor: effects on ischemic brain damage through edema and neutrophil accumulation in rat middle cerebral artery occlusion model. Brain. Res. 945, 242-248.
33. TOPSAKAL, C., EROL, F.S., OZVEREN, M.F., et al. (2002). Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury. Neurosurg. Rev. 25, 258-266.
34. UENO, T., SAWA, Y., KITAGAWA-SAKAKIDA, S., et al. (2001). Nuclear factor-κB decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. J. Thorac. Cardiovasc. Surg. 122, 720-727.